TreeWAS – Variant ID: rs4750211

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
T78.4 Allergy, unspecified	0.088	0.912	0.000
T78 Adverse effects, not elsewhere classified	0.078	0.922	0.000
T78.2 Anaphylactic shock, unspecified	0.075	0.925	0.000
T78.3 Angioneurotic oedema	0.059	0.941	0.000
T78.1 Other adverse food reactions, not elsewhere classified	0.057	0.942	0.000
T78.0 Anaphylactic shock due to adverse food reaction	0.056	0.944	0.000
T78.9 Adverse effect, unspecified	0.056	0.944	0.000
T78.8 Other adverse effects, not elsewhere classified	0.049	0.951	0.000
T66-T78 Other and unspecified effects of external causes	0.037	0.963	0.000
T66 Unspecified effects of radiation	0.031	0.969	0.000
T75 Effects of other external causes	0.030	0.969	0.000
T70 Effects of air pressure and water pressure	0.028	0.972	0.000
T74 Maltreatment syndromes	0.027	0.973	0.000
T73 Effects of other deprivation	0.027	0.973	0.000
T69 Other effects of reduced temperature	0.027	0.973	0.000
T67 Effects of heat and light	0.027	0.973	0.000
T71 Asphyxiation	0.027	0.973	0.000
T75.1 Drowning and nonfatal submersion	0.025	0.975	0.000
T75.4 Effects of electric current	0.022	0.977	0.000
T75.8 Other specified effects of external causes	0.022	0.978	0.000
T75.3 Motion sickness	0.022	0.978	0.000
T75.2 Effects of vibration	0.022	0.978	0.000
T75.0 Effects of lightning	0.022	0.978	0.000
T70.3 Caisson disease [decompression sickness]	0.021	0.979	0.000
T70.9 Effect of air pressure and water pressure, unspecified	0.020	0.980	0.000
T70.8 Other effects of air pressure and water pressure	0.020	0.980	0.000
T70.4 Effects of high-pressure fluids	0.020	0.980	0.000
T70.2 Other and unspecified effects of high altitude	0.020	0.980	0.000
T70.1 Sinus barotrauma	0.020	0.980	0.000
T70.0 Otitic barotrauma	0.020	0.980	0.000
T67.9 Effects of heat and light, unspecified	0.019	0.980	0.000
T67.8 Other effects of heat and light	0.019	0.980	0.000
T67.7 Heat oedema	0.019	0.980	0.000
T67.6 Heat fatigue, transient	0.019	0.980	0.000
T67.5 Heat exhaustion, unspecified	0.019	0.980	0.000
T67.4 Heat exhaustion due to salt depletion	0.019	0.980	0.000
T67.3 Heat exhaustion, anhydrotic	0.019	0.980	0.000
T67.2 Heat cramp	0.019	0.980	0.000
T67.1 Heat syncope	0.019	0.980	0.000
T67.0 Heatstroke and sunstroke	0.019	0.980	0.000
T69.9 Effect of reduced temperature, unspecified	0.019	0.980	0.000
T69.8 Other specified effects of reduced temperature	0.019	0.980	0.000
T69.1 Chilblains	0.019	0.980	0.000
T69.0 Immersion hand and foot	0.019	0.980	0.000
T73.9 Effect of deprivation, unspecified	0.019	0.980	0.000
T73.8 Other effects of deprivation	0.019	0.980	0.000
T73.3 Exhaustion due to excessive exertion	0.019	0.980	0.000
T73.2 Exhaustion due to exposure	0.019	0.980	0.000
T73.1 Effects of thirst	0.019	0.980	0.000
T73.0 Effects of hunger	0.019	0.980	0.000
T74.9 Maltreatment syndrome, unspecified	0.019	0.980	0.000
T74.8 Other maltreatment syndromes	0.019	0.980	0.000
T74.3 Psychological abuse	0.019	0.980	0.000
T74.2 Sexual abuse	0.019	0.980	0.000
T74.1 Physical abuse	0.019	0.980	0.000
T74.0 Neglect or abandonment	0.019	0.980	0.000
T83.8 Other complications of genito-urinary prosthetic devices, implants and grafts	0.000	0.982	0.018
T83.1 Mechanical complication of other urinary devices and implants	0.000	0.982	0.018
T83 Complications of genito-urinary prosthetic devices, implants and grafts	0.000	0.983	0.017
T83.9 Unspecified complication of genito-urinary prosthetic device, implant and graft	0.000	0.985	0.015
T68 Hypothermia	0.014	0.985	0.000
T83.6 Infection and inflammatory reaction due to prosthetic device, implant and graft in genital tract	0.000	0.986	0.014
T83.4 Mechanical complication of other prosthetic devices, implants and grafts in genital tract	0.000	0.986	0.014
T83.0 Mechanical complication of urinary (indwelling) catheter	0.000	0.987	0.013
T83.2 Mechanical complication of graft of urinary organ	0.000	0.987	0.013
T83.3 Mechanical complication of intra-uterine contraceptive device	0.000	0.988	0.012
R94.4 Abnormal results of kidney function studies	0.008	0.992	0.000
R41.8 Other and unspecified symptoms and signs involving cognitive functions and awareness	0.000	0.992	0.008
T83.5 Infection and inflammatory reaction due to prosthetic device, implant and graft in urinary system	0.000	0.993	0.007
Y85.0 Sequelae of motor-vehicle accident	0.006	0.994	0.000
N05.9 Unspecified	0.006	0.994	0.000
Z71.3 Dietary counselling and surveillance	0.006	0.994	0.000
E22.2 Syndrome of inappropriate secretion of antidiuretic hormone	0.006	0.994	0.000
O68.8 Labour and delivery complicated by other evidence of foetal stress	0.000	0.994	0.006
T43.2 Other and unspecified antidepressants	0.005	0.995	0.000
T46 Poisoning by agents primarily affecting the cardiovascular system	0.005	0.995	0.000
N05 Unspecified nephritic syndrome	0.005	0.995	0.000
O68.2 Labour and delivery complicated by foetal heart rate anomaly with meconium in amniotic fluid	0.000	0.995	0.005
T46.4 Angiotensin-converting-enzyme inhibitors	0.005	0.995	0.000
E22 Hyperfunction of pituitary gland	0.005	0.995	0.000
E23 Hypofunction and other disorders of pituitary gland	0.005	0.995	0.000
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.005	0.995	0.000
N05.8 Other	0.005	0.995	0.000
I12.9 Hypertensive renal disease without renal failure	0.000	0.995	0.005
N05.2 Diffuse membranous glomerulonephritis	0.005	0.995	0.000
Z99.1 Dependence on respirator	0.005	0.995	0.000
E23.2 Diabetes insipidus	0.005	0.995	0.000
O68.9 Labour and delivery complicated by foetal stress, unspecified	0.000	0.995	0.005
T43 Poisoning by psychotropic drugs, not elsewhere classified	0.005	0.995	0.000
O68 Labour and delivery complicated by foetal stress [distress]	0.000	0.995	0.005
T44 Poisoning by drugs primarily affecting the autonomic nervous system	0.005	0.995	0.000
N05.3 Diffuse mesangial proliferative glomerulonephritis	0.005	0.995	0.000
E23.0 Hypopituitarism	0.005	0.995	0.000
T36-T50 Poisoning by drugs, medicaments and biological substances	0.005	0.995	0.000
T43.4 Butyrophenone and thioxanthene neuroleptics	0.004	0.995	0.000
T46.1 Calcium-channel blockers	0.004	0.995	0.000
E23.7 Disorder of pituitary gland, unspecified	0.004	0.996	0.000
T46.5 Other antihypertensive drugs, not elsewhere classified	0.004	0.996	0.000
E22.1 Hyperprolactinaemia	0.004	0.996	0.000
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified	0.004	0.996	0.000
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances	0.004	0.996	0.000
E22.0 Acromegaly and pituitary gigantism	0.004	0.996	0.000
E23.6 Other disorders of pituitary gland	0.004	0.996	0.000
T46.9 Other and unspecified agents primarily affecting the cardiovascular system	0.004	0.996	0.000
T46.8 Antivaricose drugs, including sclerosing agents	0.004	0.996	0.000
T46.7 Peripheral vasodilators	0.004	0.996	0.000
T46.2 Other antidysrhythmic drugs, not elsewhere classified	0.004	0.996	0.000
T46.0 Cardiac-stimulant glycosides and drugs of similar action	0.004	0.996	0.000
T46.3 Coronary vasodilators, not elsewhere classified	0.004	0.996	0.000
S06.20 Diffuse brain injury (without open intracranial wound)	0.004	0.996	0.000
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified	0.004	0.996	0.000
T43.9 Psychotropic drug, unspecified	0.004	0.996	0.000
T43.3 Phenothiazine antipsychotics and neuroleptics	0.004	0.996	0.000
T50.4 Drugs affecting uric acid metabolism	0.004	0.996	0.000
O68.3 Labour and delivery complicated by biochemical evidence of foetal stress	0.000	0.996	0.004
N05.6 Dense deposit disease	0.004	0.996	0.000
N05.4 Diffuse endocapillary proliferative glomerulonephritis	0.004	0.996	0.000
N05.0 Minor glomerular abnormality	0.004	0.996	0.000
E20-E35 Disorders of other endocrine glands	0.004	0.996	0.000
E22.9 Hyperfunction of pituitary gland, unspecified	0.004	0.996	0.000
E22.8 Other hyperfunction of pituitary gland	0.004	0.996	0.000
N05.7 Diffuse crescentic glomerulonephritis	0.004	0.996	0.000
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics	0.004	0.996	0.000
E26 Hyperaldosteronism	0.004	0.996	0.000
R94 Abnormal results of function studies	0.004	0.996	0.000
C92.1 Chronic myeloid leukaemia	0.004	0.996	0.000
E23.3 Hypothalamic dysfunction, not elsewhere classified	0.004	0.996	0.000
E23.1 Drug-induced hypopituitarism	0.004	0.996	0.000
T43.1 Monoamine-oxidase-inhibitor antidepressants	0.004	0.996	0.000
T44.9 Other and unspecified drugs primarily affecting the nervous system	0.004	0.996	0.000
T36 Poisoning by systemic antibiotics	0.004	0.996	0.000
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified	0.004	0.996	0.000
T43.5 Other and unspecified antipsychotics and neuroleptics	0.004	0.996	0.000
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics	0.004	0.996	0.000
T43.8 Other psychotropic drugs, not elsewhere classified	0.004	0.996	0.000
N05.5 Diffuse mesangiocapillary glomerulonephritis	0.004	0.996	0.000
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified	0.004	0.996	0.000
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.004	0.996	0.000
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.004	0.996	0.000
T44.2 Ganglionic blocking drugs, not elsewhere classified	0.004	0.996	0.000
T44.1 Other parasympathomimetics [cholinergics]	0.004	0.996	0.000
T44.0 Anticholinesterase agents	0.004	0.996	0.000
R94.2 Abnormal results of pulmonary function studies	0.004	0.996	0.000
E26.0 Primary hyperaldosteronism	0.004	0.996	0.000
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system	0.004	0.996	0.000
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs	0.003	0.996	0.000
T41 Poisoning by anaesthetics and therapeutic gases	0.003	0.996	0.000
T43.6 Psychostimulants with abuse potential	0.003	0.996	0.000
T39.3 Other nonsteroidal anti-inflammatory drugs [NSAID]	0.004	0.996	0.000
T37 Poisoning by other systemic anti-infectives and antiparasitics	0.003	0.996	0.000
E26.9 Hyperaldosteronism, unspecified	0.003	0.996	0.000
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]	0.004	0.996	0.000
T50.8 Diagnostic agents	0.003	0.997	0.000
T50.7 Analeptics and opioid receptor antagonists	0.003	0.997	0.000
T50.6 Antidotes and chelating agents, not elsewhere classified	0.003	0.997	0.000
T50.5 Appetite depressants	0.003	0.997	0.000
T50.3 Electrolytic, caloric and water-balance agents	0.003	0.997	0.000
T50.1 Loop [high-ceiling] diuretics	0.003	0.997	0.000
T50.0 Mineralocorticoids and their antagonists	0.003	0.997	0.000
T36.0 Penicillins	0.003	0.997	0.000
E11.5 With peripheral circulatory complications	0.000	0.997	0.003
L43.9 Lichen planus, unspecified	0.000	0.997	0.003
T47 Poisoning by agents primarily affecting gastro-intestinal system	0.003	0.997	0.000
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified	0.003	0.997	0.000
E27 Other disorders of adrenal gland	0.003	0.997	0.000
R94.6 Abnormal results of thyroid function studies	0.003	0.997	0.000
O68.0 Labour and delivery complicated by foetal heart rate anomaly	0.000	0.997	0.003
S30.8 Other superficial injuries of abdomen, lower back and pelvis	0.003	0.997	0.000
E35 Disorders of endocrine glands in diseases classified elsewhere	0.003	0.997	0.000
E32 Diseases of thymus	0.003	0.997	0.000
E31 Polyglandular dysfunction	0.003	0.997	0.000
E30 Disorders of puberty, not elsewhere classified	0.003	0.997	0.000
E25 Adrenogenital disorders	0.003	0.997	0.000
T40.6 Other and unspecified narcotics	0.003	0.997	0.000
E26.8 Other hyperaldosteronism	0.003	0.997	0.000
E26.1 Secondary hyperaldosteronism	0.003	0.997	0.000
N05.1 Focal and segmental glomerular lesions	0.003	0.997	0.000
R94.1 Abnormal results of function studies of peripheral nervous system and special senses	0.003	0.997	0.000
R94.0 Abnormal results of function studies of central nervous system	0.003	0.997	0.000
T39.9 Nonopioid analgesic, antipyretic and antirheumatic, unspecified	0.003	0.997	0.000
E34 Other endocrine disorders	0.003	0.997	0.000
T36.9 Systemic antibiotic, unspecified	0.003	0.997	0.000
T36.8 Other systemic antibiotics	0.003	0.997	0.000
T36.7 Antifungal antibiotics, systemically used	0.003	0.997	0.000
T36.6 Rifamycins	0.003	0.997	0.000
T36.5 Aminoglycosides	0.003	0.997	0.000
T36.4 Tetracyclines	0.003	0.997	0.000
T36.3 Macrolides	0.003	0.997	0.000
T36.2 Chloramphenicol group	0.003	0.997	0.000
T36.1 Cefalosporins and other Beta-lactam antibiotics	0.003	0.997	0.000
T39.0 Salicylates	0.003	0.997	0.000
R94.8 Abnormal results of function studies of other organs and systems	0.003	0.997	0.000
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.003	0.997	0.000
T39.4 Antirheumatics, not elsewhere classified	0.003	0.997	0.000
T39.2 Pyrazolone derivatives	0.003	0.997	0.000
E27.1 Primary adrenocortical insufficiency	0.003	0.997	0.000
R94.3 Abnormal results of cardiovascular function studies	0.003	0.997	0.000
T45.1 Antineoplastic and immunosuppressive drugs	0.003	0.997	0.000
O68.1 Labour and delivery complicated by meconium in amniotic fluid	0.000	0.997	0.003
I27.2 Other secondary pulmonary hypertension	0.000	0.997	0.003
R94.7 Abnormal results of other endocrine function studies	0.003	0.997	0.000
T39.8 Other nonopioid analgesics and antipyretics, not elsewhere classified	0.003	0.997	0.000
E20 Hypoparathyroidism	0.003	0.997	0.000
H90.5 Sensorineural hearing loss, unspecified	0.000	0.997	0.003
T40.1 Heroin	0.003	0.997	0.000
Y85 Sequelae of transport accidents	0.003	0.997	0.000
O20.0 Threatened abortion	0.003	0.997	0.000
T41.5 Therapeutic gases	0.003	0.997	0.000
T41.4 Anaesthetic, unspecified	0.003	0.997	0.000
T41.3 Local anaesthetics	0.003	0.997	0.000
T41.2 Other and unspecified general anaesthetics	0.003	0.997	0.000
T41.1 Intravenous anaesthetics	0.003	0.997	0.000
T41.0 Inhaled anaesthetics	0.003	0.997	0.000
T48.7 Other and unspecified agents primarily acting on the respiratory system	0.003	0.997	0.000
T48.6 Antiasthmatics, not elsewhere classified	0.003	0.997	0.000
T48.5 Anti-common-cold drugs	0.003	0.997	0.000
T48.4 Expectorants	0.003	0.997	0.000
T48.3 Antitussives	0.003	0.997	0.000
T48.2 Other and unspecified agents primarily acting on muscles	0.003	0.997	0.000
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.003	0.997	0.000
T48.0 Oxytocic drugs	0.003	0.997	0.000
T49.9 Topical agent, unspecified	0.003	0.997	0.000
T49.8 Other topical agents	0.003	0.997	0.000
T49.7 Dental drugs, topically applied	0.003	0.997	0.000
T49.6 Otorhinolaryngological drugs and preparations	0.003	0.997	0.000
T49.5 Ophthalmological drugs and preparations	0.003	0.997	0.000
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.003	0.997	0.000
T49.3 Emollients, demulcents and protectants	0.003	0.997	0.000
T49.2 Local astringents and local detergents	0.003	0.997	0.000
T49.1 Antipruritics	0.003	0.997	0.000
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified	0.003	0.997	0.000
Z93.3 Colostomy status	0.000	0.997	0.003
T37.9 Systemic anti-infective and antiparasitic, unspecified	0.003	0.997	0.000
T37.5 Antiviral drugs	0.003	0.997	0.000
T37.4 Anthelminthics	0.003	0.997	0.000
T37.3 Other antiprotozoal drugs	0.003	0.997	0.000
T37.2 Antimalarials and drugs acting on other blood protozoa	0.003	0.997	0.000
T37.1 Antimycobacterial drugs	0.003	0.997	0.000
T37.0 Sulphonamides	0.003	0.997	0.000
T40.9 Other and unspecified psychodysleptics [hallucinogens]	0.003	0.997	0.000
T40.8 Lysergide [LSD]	0.003	0.997	0.000
T40.7 Cannabis (derivatives)	0.003	0.997	0.000
T40.3 Methadone	0.003	0.997	0.000
T40.0 Opium	0.003	0.997	0.000
E29 Testicular dysfunction	0.003	0.997	0.000
T37.8 Other specified systemic anti-infectives and antiparasitics	0.003	0.997	0.000
E27.9 Disorder of adrenal gland, unspecified	0.003	0.997	0.000
S27.00 Traumatic pneumothorax (without open wound into thoracic cavity)	0.000	0.997	0.003
T40.5 Cocaine	0.003	0.997	0.000
E34.9 Endocrine disorder, unspecified	0.003	0.997	0.000
T47.4 Other laxatives	0.003	0.997	0.000
K02.8 Other dental caries	0.000	0.997	0.003
S80.9 Superficial injury of lower leg, unspecified	0.000	0.997	0.003
T45.2 Vitamins, not elsewhere classified	0.003	0.997	0.000
Q43.0 Meckel's diverticulum	0.003	0.997	0.000
T45.9 Primarily systemic and haematological agent, unspecified	0.002	0.997	0.000
T45.8 Other primarily systemic and haematological agents	0.002	0.997	0.000
T45.7 Anticoagulant antagonists, vitamin K and other coagulants	0.002	0.997	0.000
T45.6 Fibrinolysis-affecting drugs	0.002	0.997	0.000
T45.4 Iron and its compounds	0.002	0.997	0.000
T45.3 Enzymes, not elsewhere classified	0.002	0.997	0.000
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.002	0.997	0.000
T47.8 Other agents primarily affecting the gastro-intestinal system	0.002	0.997	0.000
T47.7 Emetics	0.002	0.997	0.000
T47.6 Antidiarrhoeal drugs	0.002	0.997	0.000
T47.5 Digestants	0.002	0.997	0.000
T47.3 Saline and osmotic laxatives	0.002	0.997	0.000
T47.2 Stimulant laxatives	0.002	0.997	0.000
T47.0 Histamine H(2)-receptor antagonists	0.002	0.997	0.000
F41.2 Mixed anxiety and depressive disorder	0.003	0.997	0.000
T50.9 Other and unspecified drugs, medicaments and biological substances	0.003	0.997	0.000
E27.8 Other specified disorders of adrenal gland	0.003	0.997	0.000
E27.5 Adrenomedullary hyperfunction	0.002	0.997	0.000
E27.0 Other adrenocortical overactivity	0.002	0.997	0.000
T40.2 Other opioids	0.003	0.997	0.000
E21 Hyperparathyroidism and other disorders of parathyroid gland	0.003	0.997	0.000
E24 Cushing's syndrome	0.002	0.997	0.000
S06.2 Diffuse brain injury	0.003	0.997	0.000
M86.97 Osteomyelitis, unspecified (Ankle and foot)	0.000	0.997	0.003
E25.9 Adrenogenital disorder, unspecified	0.002	0.997	0.000
E25.8 Other adrenogenital disorders	0.002	0.997	0.000
E25.0 Congenital adrenogenital disorders associated with enzyme deficiency	0.002	0.997	0.000
E30.9 Disorder of puberty, unspecified	0.002	0.997	0.000
E30.8 Other disorders of puberty	0.002	0.997	0.000
E30.1 Precocious puberty	0.002	0.997	0.000
E30.0 Delayed puberty	0.002	0.997	0.000
E31.9 Polyglandular dysfunction, unspecified	0.002	0.997	0.000
E31.8 Other polyglandular dysfunction	0.002	0.997	0.000
E31.1 Polyglandular hyperfunction	0.002	0.997	0.000
E31.0 Autoimmune polyglandular failure	0.002	0.997	0.000
E32.9 Disease of thymus, unspecified	0.002	0.997	0.000
E32.8 Other diseases of thymus	0.002	0.997	0.000
E32.1 Abscess of thymus	0.002	0.997	0.000
E32.0 Persistent hyperplasia of thymus	0.002	0.997	0.000
E35.8 Disorders of other endocrine glands in diseases classified elsewhere	0.002	0.997	0.000
E35.1 Disorders of adrenal glands in diseases classified elsewhere	0.002	0.997	0.000
E35.0 Disorders of thyroid gland in diseases classified elsewhere	0.002	0.997	0.000
I61.9 Intracerebral haemorrhage, unspecified	0.003	0.997	0.000
E28 Ovarian dysfunction	0.002	0.997	0.000
M94.26 Chondromalacia (Lower leg)	0.002	0.997	0.000
E34.5 Androgen resistance syndrome	0.002	0.997	0.000
E34.4 Constitutional tall stature	0.002	0.997	0.000
E34.3 Short stature, not elsewhere classified	0.002	0.997	0.000
E34.2 Ectopic hormone secretion, not elsewhere classified	0.002	0.997	0.000
E34.1 Other hypersecretion of intestinal hormones	0.002	0.997	0.000
E34.8 Other specified endocrine disorders	0.002	0.998	0.000
T38.9 Other and unspecified hormone antagonists	0.002	0.998	0.000
T38.8 Other and unspecified hormones and their synthetic substitutes	0.002	0.998	0.000
T38.7 Androgens and anabolic congeners	0.002	0.998	0.000
T38.5 Other oestrogens and progestogens	0.002	0.998	0.000
T38.4 Oral contraceptives	0.002	0.998	0.000
T38.2 Antithyroid drugs	0.002	0.998	0.000
T38.0 Glucocorticoids and synthetic analogues	0.002	0.998	0.000
E27.3 Drug-induced adrenocortical insufficiency	0.002	0.998	0.000
H90.1 Conductive hearing loss, unilateral with unrestricted hearing on the contralateral side	0.000	0.998	0.002
R94.5 Abnormal results of liver function studies	0.002	0.998	0.000
M86.96 Osteomyelitis, unspecified (Lower leg)	0.000	0.998	0.002
E27.2 Addisonian crisis	0.002	0.998	0.000
H90.3 Sensorineural hearing loss, bilateral	0.000	0.998	0.002
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified	0.002	0.998	0.000
K41.9 Unilateral or unspecified femoral hernia, without obstruction or gangrene	0.002	0.998	0.000
H90 Conductive and sensorineural hearing loss	0.000	0.998	0.002
E20.8 Other hypoparathyroidism	0.002	0.998	0.000
E20.1 Pseudohypoparathyroidism	0.002	0.998	0.000
E20.0 Idiopathic hypoparathyroidism	0.002	0.998	0.000
E21.3 Hyperparathyroidism, unspecified	0.002	0.998	0.000
Z74.0 Reduced mobility	0.000	0.998	0.002
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.002	0.998	0.000
T45.0 Antiallergic and antiemetic drugs	0.002	0.998	0.000
Y85.9 Sequelae of other and unspecified transport accidents	0.002	0.998	0.000
E29.9 Testicular dysfunction, unspecified	0.002	0.998	0.000
E29.8 Other testicular dysfunction	0.002	0.998	0.000
E29.0 Testicular hyperfunction	0.002	0.998	0.000
E21.5 Disorder of parathyroid gland, unspecified	0.002	0.998	0.000
M86.9 Osteomyelitis, unspecified	0.000	0.998	0.002
C92.0 Acute myeloid leukaemia	0.002	0.998	0.000
E27.4 Other and unspecified adrenocortical insufficiency	0.002	0.998	0.000
M67.2 Synovial hypertrophy, not elsewhere classified	0.002	0.998	0.000
C92 Myeloid leukaemia	0.002	0.998	0.000
M93.9 Osteochondropathy, unspecified	0.002	0.998	0.000
T47.1 Other antacids and anti-gastric-secretion drugs	0.002	0.998	0.000
T40.4 Other synthetic narcotics	0.002	0.998	0.000
E21.4 Other specified disorders of parathyroid gland	0.002	0.998	0.000
E21.2 Other hyperparathyroidism	0.002	0.998	0.000
H90.4 Sensorineural hearing loss, unilateral with unrestricted hearing on the contralateral side	0.000	0.998	0.002
Q43.8 Other specified congenital malformations of intestine	0.002	0.998	0.000
E21.1 Secondary hyperparathyroidism, not elsewhere classified	0.002	0.998	0.000
E24.8 Other Cushing's syndrome	0.002	0.998	0.000
E24.4 Alcohol-induced pseudo-Cushing's syndrome	0.002	0.998	0.000
E24.3 Ectopic ACTH syndrome	0.002	0.998	0.000
E24.1 Nelson's syndrome	0.002	0.998	0.000
E28.3 Primary ovarian failure	0.002	0.998	0.000
S06.21 Diffuse brain injury (with open intracranial wound)	0.002	0.998	0.000
E20.9 Hypoparathyroidism, unspecified	0.002	0.998	0.000
E34.0 Carcinoid syndrome	0.002	0.998	0.000
T38.1 Thyroid hormones and substitutes	0.002	0.998	0.000
E28.9 Ovarian dysfunction, unspecified	0.002	0.998	0.000
E28.8 Other ovarian dysfunction	0.002	0.998	0.000
E28.1 Androgen excess	0.002	0.998	0.000
E28.0 Oestrogen excess	0.002	0.998	0.000
D48.5 Skin	0.002	0.998	0.000
I27.9 Pulmonary heart disease, unspecified	0.000	0.998	0.002
T45.5 Anticoagulants	0.002	0.998	0.000
M47.97 Spondylosis, unspecified (Lumbosacral region)	0.002	0.998	0.000
M79.10 Myalgia (Multiple sites)	0.002	0.998	0.000
M86.95 Osteomyelitis, unspecified (Pelvic region and thigh)	0.000	0.998	0.002
M86.94 Osteomyelitis, unspecified (Hand)	0.000	0.998	0.002
T39.1 4-Aminophenol derivatives	0.002	0.998	0.000
E24.9 Cushing's syndrome, unspecified	0.002	0.998	0.000
H90.7 Mixed conductive and sensorineural hearing loss, unilateral with unrestricted hearing on the contralateral side	0.000	0.998	0.002
I27 Other pulmonary heart diseases	0.000	0.998	0.002
Q43 Other congenital malformations of intestine	0.002	0.998	0.000
I61.5 Intracerebral haemorrhage, intraventricular	0.002	0.998	0.000
I61.4 Intracerebral haemorrhage in cerebellum	0.002	0.998	0.000
M65.34 Trigger finger-Hand	0.000	0.998	0.002
E24.2 Drug-induced Cushing's syndrome	0.002	0.998	0.000
H90.2 Conductive hearing loss, unspecified	0.000	0.998	0.002
H90.6 Mixed conductive and sensorineural hearing loss, bilateral	0.000	0.998	0.002
C92.7 Other myeloid leukaemia	0.002	0.998	0.000
E24.0 Pituitary-dependent Cushing's disease	0.002	0.998	0.000
M86.93 Osteomyelitis, unspecified (Forearm)	0.000	0.998	0.002
M86.92 Osteomyelitis, unspecified (Upper arm)	0.000	0.998	0.002
M86.91 Osteomyelitis, unspecified (Shoulder region)	0.000	0.998	0.002
M86.90 Osteomyelitis, unspecified (Multiple sites)	0.000	0.998	0.002
M94.2 Chondromalacia	0.002	0.998	0.000
Z73.9 Problem related to life-management difficulty, unspecified	0.000	0.998	0.002
M86.99 Osteomyelitis, unspecified (Site unspecified)	0.000	0.998	0.002
C92.9 Myeloid leukaemia, unspecified	0.002	0.998	0.000
C92.8 Acute myeloid leukaemia with multilineage dysplasia	0.002	0.998	0.000
C92.6 Acute myeloid leukaemia with 11q23-abnormality	0.002	0.998	0.000
C92.5 Acute myelomonocytic leukaemia	0.002	0.998	0.000
C92.3 Myeloid sarcoma	0.002	0.998	0.000
C92.2 Subacute myeloid leukaemia	0.002	0.998	0.000
E29.1 Testicular hypofunction	0.002	0.998	0.000
M70.65 Trochanteric bursitis-Pelvic/Thigh	0.000	0.998	0.002
H90.0 Conductive hearing loss, bilateral	0.000	0.998	0.002
T85.2 Mechanical complication of intraocular lens	0.000	0.998	0.002
I87.2 Venous insufficiency (chronic) (peripheral)	0.000	0.998	0.002
R03.1 Nonspecific low blood-pressure reading	0.000	0.998	0.002
I61 Intracerebral haemorrhage	0.002	0.998	0.000
L43 Lichen planus	0.000	0.998	0.002
S27.0 Traumatic pneumothorax	0.000	0.998	0.002
T43.0 Tricyclic and tetracyclic antidepressants	0.000	0.998	0.001
I27.8 Other specified pulmonary heart diseases	0.000	0.998	0.002
N18.2 Chronic kidney disease, stage 2	0.000	0.998	0.002
I27.1 Kyphoscoliotic heart disease	0.000	0.998	0.002
Q43.9 Congenital malformation of intestine, unspecified	0.002	0.998	0.000
Q43.7 Persistent cloaca	0.002	0.998	0.000
Q43.6 Congenital fistula of rectum and anus	0.002	0.998	0.000
Q43.5 Ectopic anus	0.002	0.998	0.000
Q43.4 Duplication of intestine	0.002	0.998	0.000
Q43.2 Other congenital functional disorders of colon	0.002	0.998	0.000
Q43.1 Hirschsprung's disease	0.002	0.998	0.000
C92.4 Acute promyelocytic leukaemia	0.002	0.998	0.000
S30 Superficial injury of abdomen, lower back and pelvis	0.002	0.998	0.000
N30.1 Interstitial cystitis (chronic)	0.000	0.998	0.002
H90.8 Mixed conductive and sensorineural hearing loss, unspecified	0.000	0.998	0.001
M94.29 Chondromalacia (Site unspecified)	0.001	0.998	0.000
M94.28 Chondromalacia (Other)	0.001	0.998	0.000
M94.27 Chondromalacia (Ankle and foot)	0.001	0.998	0.000
M94.25 Chondromalacia (Pelvic region and thigh)	0.001	0.998	0.000
M94.24 Chondromalacia (Hand)	0.001	0.998	0.000
M94.23 Chondromalacia (Forearm)	0.001	0.998	0.000
M94.22 Chondromalacia (Upper arm)	0.001	0.998	0.000
M94.21 Chondromalacia (Shoulder region)	0.001	0.998	0.000
M94.20 Chondromalacia (Multiple sites)	0.001	0.998	0.000
S06.50 Traumatic subdural haemorrhage (without open intracranial wound)	0.002	0.998	0.000
I61.0 Intracerebral haemorrhage in hemisphere, subcortical	0.002	0.998	0.000
Z34.9 Supervision of normal pregnancy, unspecified	0.000	0.998	0.002
S06.40 Epidural haemorrhage (without open intracranial wound)	0.002	0.998	0.000
S22.30 Fracture of rib (closed)	0.000	0.998	0.002
C16.9 Stomach, unspecified	0.002	0.998	0.000
I73.0 Raynaud's syndrome	0.002	0.998	0.000
M86.98 Osteomyelitis, unspecified (Other)	0.000	0.998	0.001
M93 Other osteochondropathies	0.002	0.998	0.000
L43.8 Other lichen planus	0.000	0.998	0.001
I61.3 Intracerebral haemorrhage in brain stem	0.001	0.998	0.000
N34.2 Other urethritis	0.000	0.998	0.002
S30.2 Contusion of external genital organs	0.001	0.998	0.000
S30.0 Contusion of lower back and pelvis	0.002	0.998	0.000
S81.8 Open wound of other parts of lower leg	0.002	0.998	0.000
H00.0 Hordeolum and other deep inflammation of eyelid	0.002	0.998	0.000
I24.9 Acute ischaemic heart disease, unspecified	0.002	0.998	0.000
L43.3 Subacute (active) lichen planus	0.000	0.998	0.001
L43.2 Lichenoid drug reaction	0.000	0.998	0.001
L43.1 Bullous lichen planus	0.000	0.998	0.001
L43.0 Hypertrophic lichen planus	0.000	0.998	0.001
M07.39 Other psoriatic arthropathies (Site unspecified)	0.002	0.998	0.000
M94.96 Disorder of cartilage, unspecified (Lower leg)	0.001	0.998	0.000
S27.01 Traumatic pneumothorax (with open wound into thoracic cavity)	0.000	0.998	0.001
I27.0 Primary pulmonary hypertension	0.000	0.998	0.002
I42.1 Obstructive hypertrophic cardiomyopathy	0.000	0.998	0.002
Q43.3 Congenital malformations of intestinal fixation	0.001	0.998	0.000
J30.4 Allergic rhinitis, unspecified	0.001	0.998	0.000
S06.5 Traumatic subdural haemorrhage	0.001	0.998	0.000
S30.7 Multiple superficial injuries of abdomen, lower back and pelvis	0.001	0.998	0.000
F32.2 Severe depressive episode without psychotic symptoms	0.001	0.999	0.000
I61.6 Intracerebral haemorrhage, multiple localised	0.001	0.999	0.000
S06.4 Epidural haemorrhage	0.001	0.999	0.000
M19.02 Primary arthrosis of other joints (Upper arm)	0.001	0.999	0.000
G93.1 Anoxic brain damage, not elsewhere classified	0.001	0.999	0.000
I79.2 Peripheral angiopathy in diseases classified elsewhere	0.000	0.999	0.001
N04.0 Minor glomerular abnormality	0.001	0.999	0.000
M94.9 Disorder of cartilage, unspecified	0.001	0.999	0.000
D68.9 Coagulation defect, unspecified	0.001	0.999	0.000
M93.8 Other specified osteochondropathies	0.001	0.999	0.000
M93.2 Osteochondritis dissecans	0.001	0.999	0.000
M93.1 Kienbock's disease of adults	0.001	0.999	0.000
M93.0 Slipped upper femoral epiphysis (nontraumatic)	0.001	0.999	0.000
N04 Nephrotic syndrome	0.001	0.999	0.000
M62.59 Muscle wasting and atrophy, not elsewhere classified (Site unspecified)	0.001	0.999	0.000
D17.0 Benign lipomatous neoplasm of skin and subcutaneous tissue of head, face and neck	0.001	0.999	0.000
M25.54 Pain in joint (Hand)	0.001	0.999	0.000
A40.8 Other streptococcal septicaemia	0.000	0.999	0.001
E53.9 Vitamin B deficiency, unspecified	0.001	0.999	0.000
M62.5 Muscle wasting and atrophy, not elsewhere classified	0.001	0.999	0.000
N04.9 Unspecified	0.001	0.999	0.000
R40.2 Coma, unspecified	0.001	0.999	0.000
M94 Other disorders of cartilage	0.001	0.999	0.000
M62.50 Muscle wasting and atrophy, not elsewhere classified (Multiple sites)	0.001	0.999	0.000
C32.1 Supraglottis	0.001	0.999	0.000
I35.0 Aortic (valve) stenosis	0.001	0.999	0.000
I61.1 Intracerebral haemorrhage in hemisphere, cortical	0.001	0.999	0.000
O71.7 Obstetric haematoma of pelvis	0.001	0.999	0.000
Z98.8 Other specified postsurgical states	0.000	0.999	0.001
M62.56 Muscle wasting and atrophy, not elsewhere classified (Lower leg)	0.001	0.999	0.000
M62.55 Muscle wasting and atrophy, not elsewhere classified (Pelvic region and thigh)	0.001	0.999	0.000
M86.67 Other chronic osteomyelitis (Ankle and foot)	0.000	0.999	0.001
S06.41 Epidural haemorrhage (with open intracranial wound)	0.001	0.999	0.000
S06.51 Traumatic subdural haemorrhage (with open intracranial wound)	0.001	0.999	0.000
C62.9 Testis, unspecified	0.001	0.999	0.000
F45.9 Somatoform disorder, unspecified	0.001	0.999	0.000
M67.0 Short Achilles tendon (acquired)	0.001	0.999	0.000
S06 Intracranial injury	0.001	0.999	0.000
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs	0.001	0.999	0.000
M62.89 Other specified disorders of muscle (Site unspecified)	0.001	0.999	0.000
M62.88 Other specified disorders of muscle (Other)	0.001	0.999	0.000
M16.3 Other dysplastic coxarthrosis	0.001	0.999	0.000
M94.0 Chondrocostal junction syndrome [Tietze]	0.001	0.999	0.000
W25.9 Unspecified place	0.000	0.999	0.001

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations